Ferrochelatase is a therapeutic target for ocular neovascularization
Ferrochelatase is a therapeutic target for ocular neovascularization
About this item
Full title
Author / Creator
Basavarajappa, Halesha D , Sulaiman, Rania S , Qi, Xiaoping , Shetty, Trupti , Sheik Pran Babu, Sardar , Sishtla, Kamakshi L , Lee, Bit , Quigley, Judith , Alkhairy, Sameerah , Briggs, Christian M , Gupta, Kamna , Tang, Buyun , Shadmand, Mehdi , Grant, Maria B , Boulton, Michael E , Seo, Seung‐Yong and Corson, Timothy W
Publisher
London: Nature Publishing Group UK
Journal title
Language
English
Formats
Publication information
Publisher
London: Nature Publishing Group UK
Subjects
More information
Scope and Contents
Contents
Ocular neovascularization underlies major blinding eye diseases such as “wet” age‐related macular degeneration (AMD). Despite the successes of treatments targeting the vascular endothelial growth factor (VEGF) pathway, resistant and refractory patient populations necessitate discovery of new therapeutic targets. Using a forward chemical genetic app...
Alternative Titles
Full title
Ferrochelatase is a therapeutic target for ocular neovascularization
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_3e824506a6224c1eb5ab5fcfef835898
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_3e824506a6224c1eb5ab5fcfef835898
Other Identifiers
ISSN
1757-4676
E-ISSN
1757-4684
DOI
10.15252/emmm.201606561
